Table 2 Indicators of possession, use, physical integrity and chemical efficacy of LLINs inspected during follow-up, Sô-Ava and Akassato, Benin 2015–2016 (N = 240)
Characteristics | Pre-pregnancy | Pregnancy visit 1 | Pregnancy visit 2 | |||
|---|---|---|---|---|---|---|
Total | Mean or proportion (95% CI) | Total | Mean or proportion (95% CI) | Total | Mean or proportion (95% CI) | |
Possession of at least one LLIN/household | 240 | 240 | 203 | |||
Yes | 237 | 98.75 (96.17; 97.60) | 239 | 99.53 (97.06; 99.94) | 202 | 99.51 (96.53; 99.93) |
No | 3 | 1.25 (0.40; 3.83) | 1 | 0.42 (0.06; 2.94) | 1 | 0.49 (0.07; 3.47) |
Possession of LLIN according to WHO standards (1 LLIN/2 people) | 237 | 239 | 202 | |||
Yes | 178 | 75.11 (69.16; 80.23) | 185 | 77.41 (71.63; 82.30) | 164 | 81.19 (75.14; 86.03) |
No | 59 | 24.89 (19.77; 30.84) | 54 | 22.59 (17.70; 28.37) | 38 | 18.81 (13.96; 24.85) |
Use of LLIN by pregnant women | 237 | 239 | 202 | |||
Yes | 199 | 83.97 (78.69; 89.13) | 203 | 84.94 (79.78; 88.96) | 178 | 88.12 (82.83; 91.93) |
No | 38 | 16.03 (11.86; 21.31) | 36 | 15.06 (11.04; 20.22) | 24 | 11.88 (8.06; 17.17) |
Physical integrity of pregnant woman’s LLIN | 237 | 239 | 202 | |||
Good | 156 | 65.82 (59.51; 71.62) | 145 | 60.67 (54.29; 66.70) | 115 | 56.93 (49.95; 63.64) |
Bad | 81 | 34.18 (28.38; 40.49) | 94 | 39.33 (33.30; 45.71) | 87 | 43.07 (36.36; 50.05) |
Physical integrity of household’s LLIN | 169 | 195 | 164 | |||
Good | 101 | 59.76 (52.12; 66.96) | 117 | 60.00 (52.91; 66.70) | 96 | 58.54 (50.77; 77.90) |
Bad | 68 | 40.24 (33.04; 47.88) | 78 | 40.00 (33.30; 47.09) | 68 | 41.46 (34.10; 49.23) |
Bio-efficacy of pregnant women’s LLIN | 198 | |||||
Yes | – | – | 12 | 6.06 (3.46; 10.41) | ||
No | – | – | 186 | |||
Bio-efficacy of household’s LLIN | 126 | |||||
Yes | – | – | 7 | 5.56 (2.64; 11.30) | ||
No | – | – | 119 | 94.44 (88.70; 97.36) | ||